CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News
Pfizer seeks FDA authorization for omicron vaccine in kids under 5 | The Hill
Pfizer asks FDA to authorize Covid booster shots that target omicron BA.5 for people ages 12 and older
Pfizer and BioNTech seek emergency use authorization for Omicron BA.4/5-adapted booster vaccine
BioNTech SE on X: "A booster dose of our Omicron BA.4/BA.5-adapted bivalent #COVID19 vaccine developed with @Pfizer has been recommended for marketing authorization by the @EMA_News' #CHMP for children 5-11. https://t.co/COyxj9fKS4 https://t.co ...
Moderna reports promising findings for updated boosters targeting Omicron variants | CIDRAP
News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut
Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health
Updated Covid-19 boosters offer protection, but new studies suggest they don't offer an edge against Omicron | CNN
Covid-19, in arrivo i vaccini aggiornati anche alle varianti omicron 4 e 5 | Wired Italia
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster | Nature Medicine
New Covid booster shots don't protect better against omicron BA.5, studies find
Aifa approva un altro vaccino efficace contro omicron BA.4 e BA.5 - Vaccinarsi in Puglia
News - CHMP Recommends Authorisation of Comirnaty Variant (BioNTech/Pfizer) Adapted to Omicron BA.4/BA.5 As Booster Vaccination for Children Aged 5 to 11 Years - Paul-Ehrlich-Institut
Pfizer asks FDA for approval to expand omicron booster to 5- to 11-year-olds | PBS NewsHour
Coronavirus e vaccinazioni - Centro Sanitario Valposchiavo
Study asks why uptake of bivalent COVID boosters low